Cargando…
Selective COX-2 inhibitor continues to be a safe alternative in patients with nonselective NSAIDs hypersensitivity
Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) cause different types of allergic and pseudo allergic reactions. This results in difficulties in clinical practice. Most cases of NSAID hypersensitivity are mediated by the inhibition of cyclooxygenase-1 enzyme (COX-1), which results in deple...
Autores principales: | Thalappil, Sherin, Al-Nesf, Maryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
HBKU Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340565/ https://www.ncbi.nlm.nih.gov/pubmed/35968519 http://dx.doi.org/10.5339/qmj.2022.fqac.4 |
Ejemplares similares
-
Sulphamethoxazole-trimethoprim induced fixed drug eruption in a patient with Chronic Granulomatous Disease
por: Rahim Thalappil, Sherin, et al.
Publicado: (2022) -
Chronic urticaria and COVID-19 vaccination: Qatar data (preliminary report of COVAC-CU-international)
por: Purayil, Saleema, et al.
Publicado: (2022) -
Correlation between skin test results and historical manifestations in patients with suspected lidocaine hypersensitivity
por: Khalil, Sally, et al.
Publicado: (2022) -
SCIG administration: A promising and patient convenient alternative for those receiving long-term IVIG
por: Hassini, Slim, et al.
Publicado: (2022) -
Subcutaneous immunoglobulin therapy for adult patients with primary immunodeficiency disease: Qatar experience
por: Thalappil, Sherin, et al.
Publicado: (2023)